Consolidated Condensed Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Product revenues	$ 366,195	$ 332,962	$ 1,102,143	$ 861,334
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of sales	$ 279,985	$ 252,610	$ 846,815	$ 657,492
Gross margin	86,210	80,352	255,328	203,842
Operating expenses:
Net research and development expenses	23,150	22,666	72,991	62,425
Selling, general and administrative expenses	38,220	34,859	113,680	96,109
Impairment of goodwill			19,509
Restructuring expenses	1,099	6	3,412	561
Total operating expenses	62,469	57,531	209,592	159,095
Operating income	23,741	22,821	45,736	44,747
Interest (expense) income, net	(3,368)	714	(9,444)	(1,285)
Foreign currency gain (loss)	2,107	(8,285)	384	(1,516)
Other income	272	361	1,058	698
Earnings before income tax	22,752	15,611	37,734	42,644
Income tax expense	6,908	5,784	15,478	13,998
Net income	$ 15,844	$ 9,827	$ 22,256	$ 28,646
Basic earnings per share	$ 0.48	$ 0.30	$ 0.67	$ 0.87
Diluted earnings per share	$ 0.48	$ 0.29	$ 0.67	$ 0.86
Weighted average number of shares – basic	32,944,386	33,162,181	33,049,097	33,105,854
Weighted average number of shares – diluted	33,196,000	33,470,439	33,310,601	33,459,750